OBJECTIVE: To estimate differences in skeletal maturity and stature from birth to age 18 years between individuals who are overweight vs normal weight in young adulthood. PATIENTS AND METHODS: Weight, length and height, and relative skeletal age (skeletal-chronological age) were assessed annually from birth to age 18 years in 521 subjects (255 women) in the Fels Longitudinal Study who were overweight or obese (body mass index (BMI) >25 kg m(-2), n=131) or normal weight (n=390) in young adulthood (18-30 years). Generalized estimating equations were used to test for skeletal maturity and stature differences by young adult BMI status. RESULTS: Differences in height increased during puberty, being significant for girls at ages 10 to 12 years, and for boys at ages 11 to 13 years (P-values<0.001), with overweight or obese adults being ∼3 cm taller at those ages than normal weight adults. These differences then diminished so that by age 18 years, overweight or obese adults were not significantly different in stature to their normal weight peers. Differences in skeletal maturity were similar, but more pervasive; overweight or obese adults were more skeletally advanced throughout childhood. Skeletal maturity differences peaked at chronological age 12 in boys and 14 in girls (P-values<0.001), with overweight or obese adults being ∼1 year more advanced than normal weight adults. CONCLUSIONS: This descriptive study is the first to track advanced skeletal maturity and linear growth acceleration throughout infancy, childhood and adolescence in individuals who become overweight, showing that differences occur primarily around the time of the pubertal growth spurt. Increased BMI in children on a path to becoming overweight adults precedes an advancement in skeletal development and subsequently tall stature during puberty. Further work is required to assess the predictive value of accelerated pubertal height growth for assessing obesity risk in a variety of populations.
OBJECTIVE: To estimate differences in skeletal maturity and stature from birth to age 18 years between individuals who are overweight vs normal weight in young adulthood. PATIENTS AND METHODS: Weight, length and height, and relative skeletal age (skeletal-chronological age) were assessed annually from birth to age 18 years in 521 subjects (255 women) in the Fels Longitudinal Study who were overweight or obese (body mass index (BMI) >25 kg m(-2), n=131) or normal weight (n=390) in young adulthood (18-30 years). Generalized estimating equations were used to test for skeletal maturity and stature differences by young adult BMI status. RESULTS: Differences in height increased during puberty, being significant for girls at ages 10 to 12 years, and for boys at ages 11 to 13 years (P-values<0.001), with overweight or obese adults being ∼3 cm taller at those ages than normal weight adults. These differences then diminished so that by age 18 years, overweight or obese adults were not significantly different in stature to their normal weight peers. Differences in skeletal maturity were similar, but more pervasive; overweight or obese adults were more skeletally advanced throughout childhood. Skeletal maturity differences peaked at chronological age 12 in boys and 14 in girls (P-values<0.001), with overweight or obese adults being ∼1 year more advanced than normal weight adults. CONCLUSIONS: This descriptive study is the first to track advanced skeletal maturity and linear growth acceleration throughout infancy, childhood and adolescence in individuals who become overweight, showing that differences occur primarily around the time of the pubertal growth spurt. Increased BMI in children on a path to becoming overweight adults precedes an advancement in skeletal development and subsequently tall stature during puberty. Further work is required to assess the predictive value of accelerated pubertal height growth for assessing obesity risk in a variety of populations.
Authors: D L Russell; M F Keil; S H Bonat; G I Uwaifo; J C Nicholson; J R McDuffie; S C Hill; J A Yanovski Journal: J Pediatr Date: 2001-12 Impact factor: 4.406
Authors: Steven D Stovitz; Peter J Hannan; Leslie A Lytle; Ellen W Demerath; Mark A Pereira; John H Himes Journal: Am J Prev Med Date: 2010-01 Impact factor: 5.043
Authors: Maya B Lodish; Evgenia Gourgari; Ninet Sinaii; Suvimol Hill; Laura Libuit; Spyridon Mastroyannis; Margaret Keil; Dalia L Batista; Constantine A Stratakis Journal: J Pediatr Date: 2014-01-10 Impact factor: 4.406
Authors: Jose Cordoba-Chacon; Manuel D Gahete; Ana I Pozo-Salas; Antonio Moreno-Herrera; Justo P Castaño; Rhonda D Kineman; Raúl M Luque Journal: Am J Physiol Endocrinol Metab Date: 2012-08-28 Impact factor: 4.310
Authors: William Johnson; Laura E Soloway; Darin Erickson; Audrey C Choh; Miryoung Lee; William C Chumlea; Roger M Siervogel; Stefan A Czerwinski; Bradford Towne; Ellen W Demerath Journal: Am J Clin Nutr Date: 2012-03-14 Impact factor: 7.045
Authors: Kathryn E Kyler; Jonathan Wagner; Chelsea Hosey-Cojocari; Kevin Watt; Valentina Shakhnovich Journal: Paediatr Drugs Date: 2019-10 Impact factor: 3.022
Authors: Neera Gupta; Robert H Lustig; Howard Andrews; Francisco Sylvester; David Keljo; Alka Goyal; Ranjana Gokhale; Ashish S Patel; Stephen Guthery; Cheng-Shiun Leu Journal: Inflamm Bowel Dis Date: 2020-11-19 Impact factor: 5.325
Authors: Dennis M Styne; Silva A Arslanian; Ellen L Connor; Ismaa Sadaf Farooqi; M Hassan Murad; Janet H Silverstein; Jack A Yanovski Journal: J Clin Endocrinol Metab Date: 2017-03-01 Impact factor: 5.958